Werewolf Therapeutics (HOWL)
(Delayed Data from NSDQ)
$2.28 USD
-0.33 (-12.64%)
Updated Aug 27, 2024 04:00 PM ET
After-Market: $2.28 0.00 (0.00%) 5:46 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.41 | 0.00% |
Earnings Summary
For their last quarter, Werewolf Therapeutics (HOWL) reported earnings of -$0.43 per share, missing the Zacks Consensus Estimate of -$0.38 per share. This reflects a negative earnings surprise of 13.16%. Look out for HOWL's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.41 per share, reflecting a year-over-year decrease of 78.26%.
Earnings History
Price & Consensus
Zacks News for HOWL
SpringWorks Therapeutics (SWTX) Reports Q2 Loss, Tops Revenue Estimates
HOWL: What are Zacks experts saying now?
Zacks Private Portfolio Services